Catalent Pharma Solutions, the largest company in the pharma CMO/CDMO space, announced that its parent company, Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock. The number of shares to be offered and their price range have not been determined. According to a Catalent statement, the company would use the proceeds from the offering to repay debt, with remaining funds...